Resources
About Us
Meticulous Research®—a leading market research company, published a research report titled, ‘Pulse Oximeter Market Size, Share, Forecast, & Trends Analysis by Component (Device {Prescription, OTC}, SPO2 Sensors) Portability (Handheld, Wearable, Fingertip) Technology (Connected, Conventional) Age (Adult, Pediatric) End User – Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, the pulse oximeter market is projected to reach $3.40 billion by 2031, at a CAGR of 5.4% from 2024 to 2031. The growth of the pulse oximeter market is mainly driven by the rising number of hospitalizations, the use of pulse oximeters in newborn screening, the growing incidence of Chronic Obstructive Pulmonary Disorder (COPD) and asthma, and the increasing penetration of OTC pulse oximeters. However, data accuracy and reliability concerns and regulatory concerns related to over-the-counter (OTC) pulse oximeters restrain the growth of this market. Furthermore, technological advancements in pulse oximeters, the increasing adoption of wearable devices, and advancements in sensor technologies are expected to generate growth opportunities for the players operating in this market. However, the emergence of alternative mobile-based technologies for monitoring blood oxygen levels is a challenge impacting the growth of the pulse oximeter market.
The key players profiled in the pulse oximeter market report are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Masimo Corporation (U.S.), Beurer GmbH (Germany), Nonin Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), and Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.) (U.S.).
The pulse oximeter market is segmented by Component (Devices [Prescription Pulse Oximeters and Over-the-counter {OTC} Pulse Oximeters] and Sensors [Disposable SpO2 Sensors and Reusable SpO2 Sensors]), Portability (Handheld Pulse Oximeters, Fingertip Pulse Oximeters, Wearable Pulse Oximeters, and Bench-top Pulse Oximeters), Technology (Conventional Pulse Oximeters and Connected Pulse Oximeters), Age Group (Adults, Pediatrics [Fetal Monitoring, Neonatal Monitoring, Infant Monitoring]), End User (Hospitals & Clinics, Home Care Settings, Ambulatory Care Centers, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Based on component, in 2024, the devices segment is expected to account for the larger share of the pulse oximeter market. The segment’s large share is attributed to the rising geriatric population coupled with the growing burden of chronic diseases, the increasing use of pulse oximeters by athletes and fitness enthusiasts to monitor their oxygen saturation levels during workouts, and the growing adoption of wearable technologies. The integration of pulse oximetry into wearable devices has enabled convenient and continuous monitoring of oxygen saturation levels. The data generated by wearable devices can be integrated with pulse oximeters to assess respiratory function, detect abnormalities, and identify potential health issues such as sleep apnea and respiratory infections.
Based on portability, the fingertip pulse oximeters segment is expected to record the highest CAGR during the forecast period. Fingertip devices are compact and user-friendly. The high growth of this segment is attributed to the low power consumption, accurate readings, small sizes, light weight, and ease of use offered by fingertip pulse oximeters. These devices also enable the early detection of low blood oxygen saturation levels, supporting the high growth of this segment.
Based on technology, in 2024, the conventional pulse oximeters segment is expected to account for the larger share of the pulse oximeter market. The segment’s large share is attributed to the high adoption of handheld devices in primary healthcare settings and emergency departments and the low cost of conventional pulse oximeters. Conventional pulse oximeters are easy to use and more affordable compared to connected devices. This makes them accessible to a wide range of healthcare facilities, including primary care clinics, urgent care centers, and resource-limited settings. Thus, the wide acceptance of conventional pulse oximeters supports the segment’s large market share.
Based on age group, the pediatrics segment is expected to record the highest CAGR during the forecast period. The use of pulse oximeters has increased due to growing awareness regarding newborn screening for congenital diseases, inherited disorders, and metabolic disorders, among others. Also, the increasing number of newborn disease cases and the rising number of companies offering newborn and fetal screening support the segment’s high growth. The rising number of approvals for pulse oximeters for newborn screening also supports the segment’s high growth. For instance, in June 2023, Owlet Baby Care, Inc. (U.S.) received FDA approval for its BabySat device, a wire-free sock with pulse oximetry technology that can measure heart rate and oxygen saturation levels in babies. If the parameters are exceeded, the guardians are informed through an app.
Based on end user, the home care settings segment is expected to register the highest CAGR over the forecast period, mainly due to the growing trend of home care, the rising geriatric population necessitating long-term home care, and the development of pulse oximeters for home care settings and remote patient monitoring. Healthcare providers can remotely monitor patients' oxygen saturation levels in real time using connected pulse oximeters, enabling early detection of health issues and timely intervention without the need for in-person visits. Thus, the increasing penetration of home care and remote patient monitoring supports the segment’s high growth.
Based on geography, in 2024, North America is expected to account for the largest share of the pulse oximeters market. North America’s large share is attributed to the increased penetration of telehealth services driving the use of connected pulse oximeters, the robust healthcare system in the region, and the presence of key market players.
Key Players
Some of the key market players operating in North America are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), Masimo Corporation (U.S.), Nonin Medical, Inc. (U.S.), Owlet Baby Care, Inc. (U.S.), ICU Medical, Inc. (U.S.), and GE HealthCare Technologies, Inc. (U.S.).
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5867
Key Questions Answered in the Report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More